Top compounds associated with response to TMEM262


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.15 8e-07
mRNA clofarabine CTRPv2 pan-cancer AAC -0.14 4e-06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA CD-437 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA etoposide CTRPv2 pan-cancer AAC -0.12 5e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 6e-05
mRNA alisertib CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.12 0.0001
Download CSV